Ashton Thomas Private Wealth’s AstraZeneca AZN Stock Holding History

Ashton Thomas Private Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$542K	Buy	2,872 +538	+23%	+$101K	0.01%	753
2026 Q1	$457K	Buy	2,334 +81	+4%	+$15.6K	0.01%	747
2025 Q4	$414K	Buy	2,253 +428	+23%	+$75.1K	0.01%	718
2025 Q3	$280K	Buy	1,825 +314	+21%	+$47.5K	0.01%	823
2025 Q2	$211K	Sell	1,511 -162	-10%	-$22.7K	0.01%	792
2025 Q1	$246K	Buy	+1,673	New	+$242K	0.01%	714
2024 Q3	–	Sell	-1,003	Closed	-$156K	–	717
2024 Q2	$156K	Buy	+1,003	New	+$151K	0.01%	640
2023 Q3	–	Sell	-1,876	Closed	-$269K	–	566
2023 Q2	$269K	Buy	+1,876	New	+$276K	0.02%	501

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ashton Thomas Private Wealth's AZN Position: Q2 2026 in Review

Ashton Thomas Private Wealth increased its AstraZeneca (AZN) stake by 23% in Q2 2026, buying an estimated $101K and bringing the position to 2,872 shares worth $542K. The position accounts for 0.01% of the portfolio, ranked #753.

Ashton Thomas Private Wealth first reported a position in AZN in Q2 2023 and has held it in 8 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Ashton Thomas Private Wealth held 2,872 shares of AstraZeneca worth $542K as of Q2 2026.
Ashton Thomas Private Wealth bought 538 AstraZeneca shares in Q2 2026, an estimated $101K.
AstraZeneca made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #753 holding.
Ashton Thomas Private Wealth first reported a position in AstraZeneca in Q2 2023 and has held it in 8 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.